title: Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY.
authors.affiliation: Novartis Pharma, Istanbul, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Saylan
authors.affiliation: Novartis Pharma, Istanbul, Turkey.
authors.forename: V
authors.initials: V
authors.lastname: Beykoz
authors.affiliation: Novartis Pharma, Istanbul, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Keskinaslan